---
module: 065-01
language: en
chapter: 65
title: "Epidemiology, Screening, Vaccination, Prevention, and Population Health"
module_title: "Foundations"
source_sha256: fa0b76b8691084e109bf9556cec701639cafea7d55043dec38909a46a4faf175
---
# Epidemiology, screening, vaccination, and population health

## Orientation
### Why disease occurs unevenly
### Housing, income, education, food, work, access
#### Determine illness and recovery
### Evidence with fairness, feasibility, trust, harm

## Measures of disease
### Incidence: new events among people at risk
### Prevalence: existing disease at point or period
#### Depends on incidence and duration
#### Chronic survivable disease: high prevalence
### Case fatality: diagnosed cases who die
### Risk is probability, rate uses person-time
### Absolute difference versus relative ratio
#### Rare outcome: large relative, small absolute
### Number needed to treat: 1 / absolute reduction
#### State time horizon and baseline risk
### Standardisation depends on chosen reference
### Ecological data cannot apply to individuals

## Prevention levels
### Primordial: prevents emergence of risk
### Primary: prevents disease before onset
### Secondary: early detection and prompt treatment
### Tertiary: limits complication and disability
### Quaternary: protects from unnecessary intervention
### Upstream measures reach more than counselling
#### Safe water needs no repeated individual choice
#### Taxes and labelling should avoid regressive burden

## Screening principles
### Aim is less morbidity or mortality
### Needs detectable preclinical phase
#### Effective earlier treatment and defined pathway
### Low prevalence: false positives outnumber true
### Harms: anxiety, follow-up, overdiagnosis
### Length bias favours slow disease
### Lead-time bias lengthens apparent survival
#### Randomised outcomes beat stage shift
### Sensitive test, then specific confirmation
### Programme can widen inequity
### Opportunistic testing without follow-up fails

## Vaccination and immune protection
### Antigen exposure creates memory B and T cells
### Conjugation recruits T-cell help
### Adjuvants enhance innate signalling
### Effectiveness varies with host and pathogen
#### Severe disease prevented better than infection
### Herd threshold varies with transmissibility
### Events after vaccination not necessarily caused
#### Compare background rates, timing, mechanism
### Live vaccines replicate
#### Avoided in severe immune suppression, pregnancy
### Vaccinate before immune-suppressive treatment
### Missed doses continue, not restart

## Cardiovascular and metabolic prevention
### Estimate absolute cardiovascular risk
#### Risk factors act together
### Accurate, repeated blood-pressure measurement
### Lipid benefit follows baseline risk
### Statin effects evaluated, prevention kept
### Antiplatelet: bleeding outweighs low-risk benefit
### Obesity care avoids stigma
### Adjust goals for frailty and life expectancy

## Cancer prevention and early detection
### Tobacco control prevents multiple cancers
### Papillomavirus and hepatitis B vaccination
### Chemoprevention only if risk justifies harm
### Cervical, breast, colorectal, lung programmes
### A test existing is not a reason to screen
#### Thyroid, ovarian, pancreatic overdiagnosis

## Infectious-disease prevention
### Match precautions to transmission route
### Protective equipment is one layer only
#### Fails with poor systems, ventilation, staffing
### Antimicrobial resistance from shared exposure
#### Narrow therapy, correct dose and duration
#### No antibiotics for viral illness
### One Health: shared ecosystems

## Tobacco, alcohol, and substance prevention
### Behavioural support plus pharmacotherapy
### Long-acting plus short-acting nicotine
### Relapse prompts support, not blame
### Alcohol risk varies by dose and pattern
### Naloxone and agonist treatment reduce death

## Health equity and implementation
### Equal gives same resource
### Equitable responds to barriers and need
### Identity is not biology
### Community co-design builds trust
### Evaluate reach, uptake, harm, distribution
### Healthier choices made practical and ordinary
